We sensitized sheep erythrocytes (SRBC) with antibodies against human rotavirus strain Wa (SRBC-antiWa) and antibodies against calf rotavirus strain NCDV (SRBC-antiNCDV). These were readily agglutinated in the presence of homologous antigens, i.e., human rotavirus and calf rotavirus. By the hemagglutination of SRBC-antiWa and SRBC-antiNCDV (reverse passive hemagglutination [RPHA]), titration of rotavirus in extracts from feces of children suffering from diarrhea (61 specimens) was carried out. We found that the ratio of titers determined with SRBC-antiWa and SRBC-antiNCDV varied remarkably from specimen to specimen. This indicated that the antigenic determinants on human rotavirus in patients feces cross-react with antibodies against NCDV to varying extents. To express the cross-reactivity of human rotavirus with antibodies to NCDV, we propose a WaINCDV rotavirus index which can be calculated from the RPHA titer with SRBC-antiWa and SRBC-antiNCDV as follows: Wa/NCDV rotavirus index = (antiWa-RPHA titer of specimen/antiWa-RPHA titer of NCDV)/(antiNCDV-RPHA titer of specimen/antiNCDV-RPHA titer of NCDV).
patients' stools by hemagglutination of the indicator cells (18) . Although the RPHA test with SRBC-antiNCDV showed a sensitivity comparable to that of EM, it might fail to detect HRV, which had no antigenic determinants reactive with NCDV. Therefore, we attempted to improve the RPHA method by using anti-HRV instead of anti-NCDV. Since, Wyatt et al. have succeeded in establishing an HRV strain, called the "Wa" strain (Wa) (24) , to grow in vitro, we prepared antibody to Wa (anti-Wa) by immunizing guinea pigs with Wa and purified anti-Wa with a Wa-coupled Sepharose 4B column. With this purified antibody, we coated SRBC (SRBCantiWa) for use in the RPHA test. The reactivities of this SRBC-antiWa and that of SRBCantiNCDV in the RPHA test were compared with patints' feces.
MATERIALS AND METHODS
Fecal samples. Fecal samples were obtained from infants with gastroenteritis admitted to Tachikawa Kyosai hospital and Takei Pediatric Clinic and were stored at -20°C until used. Wa, 0.5 ,ug of trypsin per ml was added to the maintenance medium. The culture fluid containing Wa was centrifuged at 54,900 x g for 4 h at 4°C, and the deposited virus was suspended in 0.001 M Tris-hydrochloride buffer containing 0.1 M NaCl (pH 7.2). The virus suspension was centrifuged in a sucrose density gradient (20 to 60%, wt/wt), and the purified Wa fraction was obtained as described for NCDV purification (20) . Antiserum against Wa was prepared by immunizing guinea pigs by the same protocol described for producing antiserum against NCDV (18, 20) . The antibody was purified by affinity chromatography on a column of Sepharose 4B conjugated with Wa. Antibody bound to the column was eluted with 3 M NaSCN, and the eluted antibody was dialyzed against saline. The purified anti-Wa (immune adherence hemagglutination titer, 1,600) was fixed to SRBC treated with tannic acid after glutaraldehyde treatment as described previously (18, 19) .
Preparation of specimens for RPHA tests. One volume of feces was mixed with 9 volumes of a 5% suspension of glutaraldehyde-treated SRBC in 0.067 M phosphate-buffered saline, pH 7.2 (PBS), and the mixture was thoroughly homogenized. In this manner the fixed SRBC absorbed hemagglutinins to SRBC which interfered with results of the rotavirus RPHA. The homogenate was incubated at 37°C for 30 min and then centrifuged at 3,000 rpm for 20 min. To the supernatant fluid was added an equal volume of trifluorochloroethane to remove substances which might interfere with the sedimentation of SRBC-antiNCDV and SRBC-antiWa. The mixture was centrifuged at 3,000 rpm for 30 min, and the supernatant fluid was used as the specimen for RPHA tests.
RPHA tests. RPHA tests were carried out on a microtitration plate as described previously (18) . Serial twofold dilutions of the specimens were made in quadruplicate in PBS containing 1.5% normal rabbit serum. In a dilution series for the test proper, 25 ,ul of PBS-normal rabbit serum was added to each well, and in a corresponding set of dilutions, the same amount of anti-Wa or anti-NCDV (complement fixation titer, 160) was added as a blocking reagent to confirm the specificity of the RPHA. The mixtures were incubated for 1 h at 37°C, and then 25 RI1 of a 0.6% suspension of SRBC-antiWa or SRBC-antiNCDV was added to each well. After shaking, the tray was kept at room temperature for 1 h or more and hemagglutination patterns were read. A fourfold or greater specific reduction of hemagglutination titer by the blocking test, with corresponding antibody, was regarded as an indication of a positive reaction.
Isolation of rotavirus by tissue culture. Isolation of HRV was carried out as described before (22) . A 10% fecal suspension in Eagle minimum essential medium containing 1,000 U of penicillin and 1,000 ,ug of streptomycin per ml was thoroughly mixed and centrifuged at 3,000 rpm for 30 min. The supernatant fluid was collected and centrifuged at 3,000 rpm for 30 min again. To the supernatant fluid was added an equal volume of 10 ,ug of trypsin per ml, and the mixture was incubated at 37°C for 20 min, after which 0. EM observations. A 5-ml portion of fecal specimen prepared for RPHA tests as described above was centrifuged at 40,000 rpm for 2 h. The pellet was resuspended in 0.2 ml of distilled water and stained with 2% phosphotungstic acid to examine in a JEM-100B JEOL EM. To examine the morphology of Wa fractionated by a sucrose density gradient, 1 drop of each fraction was layered on a grid and dried at room temperature. The grid was washed with distilled water, and the specimen was stained with 2% phosphotungstic acid to examine by EM.
RESULTS
Sensitivity of SRBC-antiWa and SRBC-antiNCDV for detection of rotavirus particles.
SRBC-antiWa and SRBC-antiNCDV prepared as described above were evaluated for their sensitivity in detection of Wa and NCDV by determining minimum numbers of virus particles detectable by RPHA tests. SRBC-antiWa could detect Wa and NCDV at dilutions of 1:64,000 and 1:1,600, respectively (Table 1) . SRBC-antiNCDV could detect Wa and NCDV at dilutions of 1:2,000 and 1:1,600, respectively. The number of virus particles in the original preparations of Wa and NCDV were determined by EM, using latex particles as a reference of counts as described previously (20) . Wa and NCDV preparations contained 1012 and 4.3 x 1010 virus particles, respectively (Table 1) SRBC-antiNCDV. The 29 specimens which agglutinated SRBC-antiNCDV all had the ability to agglutinate SRBC-antiWa. These results indicated that SRBC-antiWa could detect rotavirus which could not be detected with SRBC-antiNCDV. Figure 1 shows the relationship between the RPHA titers with SRBC-antiWa and those with SRBC-antiNCDV. The 20 specimens which did not agglutinate SRBC-antiNCDV showed RPHA titers of 8 to 2,048 with SRBCantiWa.
EM examination for HRV was also carried out on the specimens. All specimens with HRV detectable by EM showed RPHA titers of more than 8 when examined with SRBC-antiWa.
Wa/NCDV rotavirus index (Wa/NCDV index). Since the ratio of RPHA titers with SRBCantiWa and those with SRBC-antiNCDV varied remarkably from specimen to specimen (Fig. 1) , we attempted to express the nature of rotavirus by the ratio of RPHA titers. For this purpose, the RPHA titer of a NCDV preparation with SRBC-antiWa and that with SRBC-antiNCDV were used as standards. The RPHA titer with SRBC-antiWa (antiWa-RPHA titer) of a test specimen was divided by the antiWa-RPHA titer of a standard NCDV. The RPHA titer with SRBC-antiNCDV (antiNCDV-RPHA titer) of the specimen was also divided by the antiNCDV-RPHA titer of a standard NCDV. Then the ratio of the former and the latter was tentatively designated as the Wa/NCDV index: Wa/NCDV index = (antiWa-RPHA titer of specimen/antiWa-RPHA titer of NCDV)/(antiNCDV-RPHA titer of specimen/antiNCDV-RPHA titer of NCDV). When a specimen did not have a detectable RPHA titer with SRBC-antiNCDV, the titer was considered to be 2 or less. With this index, the results shown in Fig. 1 were expressed in Fig. 2 . As a control, cultured rotavirus Wa was also examined, and it showed a Wa/NCDV index of 32. Most of specimens showed a Wa/NCDV index of more than 32, and the ratios ranged up to more than 2,048.
Wa/NCDV index of intact and degraded Wa. It was conceivable that HRV which failed to react with SRBC-antiNCDV might be digested or broken rotavirus which had lost antigens reactive with anti-NCDV antibodies. To examine this possibility, Wa was fractionated by sucrose density gradient ultracentrifugation to separate native and degraded viruses in the Wa preparation. Wa propagated in MA-104 cells was concentrated 100 times, and 0.5 ml of the concentrated virus suspension was layered on top of a 4.5-ml sucrose density gradient (20 to 60%, wt/wt) and centrifuged at 36,000 rpm for 90 min. Five-drop fractions were collected through a pinhole at the bottom of the gradient.
RPHA titers of each fraction are shown in Fig.  3 . The titers with SRBC-antiWa were four times or more higher than those with SRBC-antiNCDV for all fractions except no. 18 . In fraction 9 (Wa/NCDV index, 8), most viruses were complete particles with outer membrane, and in fraction 13 Wa/NCDV index, 32), incomplete particles without outer membrane were dominant as shown by EM (Fig. 4) . Since RPHA with SRBC-antiNCDV was undetectable, the titer was tentatively regarded as 2 to calculate the index. Therefore, the actual index will be higher than the position indicated with this mark. In previous RPHA tests we used SRBC-antiNCDV as inidcator cells of hemagglutination. However, Yolken et al. (25) indicated that antisera to NCDV could not effectively detect small amounts of rotavirus in human feces, and Zissis et al. (26) demonstrated that some HRV failed to cross-react with antiserum to NCDV. Therefore, we attempted to replace SRBC-antiNCDV with SRBC-antiHRV for RPHA tests. Antibody to HRV was prepared by immunizing guinea pigs with the Wa strain of HRV which Wyatt et al. (24) adapted to in vitro growth in MA-104 cells. Anti-Wa was used to prepare SRBCantiWa by the same procedure used for preparation of SRBC-antiNCDV (18, 19) . To examine the effectiveness of substituting SRBC-antiNCDV with SRBC-antiWa for RPHA tests, we determined HRV titers in RPHA with SRBCantiWa and SRBC-antiNCDV on fecal specimens of 61 patients with infantile diarrhea.
In this study, SRBC-antiWa was considerably more efficient for the detection of HRV than was SRBC-antiNCDV. Of 49 specimens positive by SRBC-antiWa, only 29 were also positive with SRBC-antiNCDV. These 20 specimens which were missed were not false positive as each was also positive by EM. These findings differed from our previous report that SRBC-antiNCDV was more efficient than EM for the detection of HRV. The reason for this discrepancy may be due to the use of different specimens in the two studies. The specimens used in the previous study may have contained prevailing HRV strains which were more reactive with SRBCantiNCDV.
Since the ratio of RPHA titers with SRBCantiWa and SRBC-antiNCDV varied significantly (Fig. 1 2  8  2  <2  <2  <2  <2  NTC  NT  NT  NT  6  32  <2  <2  <2  <2  <2  NT  NT  NT  NT  14  2,048  8  <2  <2  <2  <2  NT  NT  NT  NT  17  512  <2  8  <2  4  <2  16  <2  256  2  20  1,024  124  <2  <2  <2  <2  NT  NT  NT  NT  25  256  2  <2  <2  <2  <2  NT  NT  NT (9) have classified rotaviruses into subgroups 1 and 2 by immune adherence hemagglutination and enzyme-linked immunosorbent assay. Since the Wa/NCDV index of NCDV (subgroup 1) was calculated as 1 and the index of Wa (subgroup 2) was calculated as 32, our index is in keeping with the classification of subgroups 1 and 2. However, our index does not separate subgroups since subgroupspecific antibody was not used in our present system. Subgroup-specific antisera such as those Kapikian et al. have developed by using group-specific postinfection antiserum from gnotobiotic calves are not generally available at this time. However, our index may contribute a simple method to determine the antigenic characteristics of HRV epidemic in the field. Replacement of the polyclonal antibodies to HRV and NCDV used in this study with monoclonal antibodies may improve our index so that it will be able to identify subgroups.
